The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, AstraZeneca Pharma India's share price is ₹5757.75.
AstraZeneca Pharma India's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹478.78. Hence, AstraZeneca Pharma India's PS Ratio for today is 12.03.
The historical rank and industry rank for AstraZeneca Pharma India's PS Ratio or its related term are showing as below:
BOM:506820'
s PS Ratio Range Over the Past 10 Years
Min: 3.8 Med: 6.43 Max: 14.75
Current: 10.98
During the past 13 years, AstraZeneca Pharma India's highest PS Ratio was 14.75. The lowest was 3.80. And the median was 6.43.
BOM:506820's PS Ratio is ranked worse than 89.62% of 1002
companies
in the Drug Manufacturers industry
Industry Median: 2.22
vs BOM:506820: 10.98
During the past 12 months, the average Revenue per Share Growth Rate of AstraZeneca Pharma India was 25.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 6.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 9.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 9.00% per year.
During the past 13 years, AstraZeneca Pharma India's highest 3-Year average Revenue per Share Growth Rate was 25.90% per year. The lowest was -7.30% per year. And the median was 7.80% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AstraZeneca Pharma India's PS Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, AstraZeneca Pharma India's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AstraZeneca Pharma India's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AstraZeneca Pharma India's PS Ratio distribution charts can be found below:
* The bar in red indicates where AstraZeneca Pharma India's PS Ratio falls into.
AstraZeneca Pharma India PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
AstraZeneca Pharma India's Share Price of today is ₹5757.75. AstraZeneca Pharma India's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹478.78.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
AstraZeneca Pharma India (BOM:506820) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
AstraZeneca Pharma India PS Ratio Related Terms
Thank you for viewing the detailed overview of AstraZeneca Pharma India's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
AstraZeneca Pharma India (BOM:506820) Business Description
AstraZeneca Pharma India Ltd is engaged in the manufacture, distribution, and marketing of pharmaceutical products. Its only operating segment being Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation and Autoimmunity, Neuroscience and Infection and Vaccines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:506820 has been successfully added to your 